Shengjie Wu Jiabing Wang Li Jing Liping Chen
10.3389/fendo.2020.608966
Front Endocrinol (Lausanne)
2021 Jan 28;11:608966.
diabetes mellitus glucagon-like peptide-1 (glp-1) glucose-dependent insulinotrophic polypeptide (gip) liraglutide pancreatic cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/33584541/
Carcinoma, Pancreatic Ductal / chemically induced Carcinoma, Pancreatic Ductal / complications Diabetes Mellitus, Type 2 / complications Hypoglycemic Agents / adverse effects Liraglutide / adverse effects Pancreatic Neoplasms / chemically induced Pancreatic Neoplasms / complications
Carcinoma, Pancreatic Ductal / chemically induced Carcinoma, Pancreatic Ductal / complications Diabetes Mellitus, Type 2 / complications Hypoglycemic Agents / adverse effects Liraglutide / adverse effects Pancreatic Neoplasms / chemically induced Pancreatic Neoplasms / complications Case Reports Research Support, Non-U.S. Gov't Aged Biopsy Carcinoma, Pancreatic Ductal / diagnostic imaging Humans Hypoglycemic Agents / therapeutic use Liraglutide / therapeutic use Lymphatic Metastasis Male Pancreas / diagnostic imaging Pancreas / pathology Pancreatic Neoplasms / diagnostic imaging Tomography, X-Ray Computed Hypoglycemic Agents Liraglutide
PMC7876378
33584541
A Diabetic Patient Complicated With Pancreatic Cancer After Using Liraglutide: A Case Report
2021